phase ii results for pembrolizumab monotherapy in metastatic tnbc
Published 7 years ago • 217 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
2:50
results for pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer
-
1:38
treatments under investigation for metastatic tnbc
-
1:36
dr. hurvitz on pembrolizumab for tnbc
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
1:33
efficacy and safety results for pembrolizumab in previously treated gastric cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:07
precision medicine for metastatic triple-negative breast cancer
-
2:45
final keynote-048 results with frontline pembrolizumab in recurrent/metastatic hnscc
-
2:20
systemic therapy for recurrent metastatic tnbc
-
0:56
pembrolizumab as adjuvant therapy for tnbc
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
2:00
pembrolizumab plus chemotherapy show efficacy for tnbc in keynote-355
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
5:38
case 4: olympiad trial for brca metastatic tnbc
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer